vs
Cycurion, Inc.（CYCU）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是Cycurion, Inc.的1.7倍（$6.0M vs $3.5M），Profound Medical Corp.净利率更高（-136.8% vs -141.2%，领先4.5%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
CYCU vs PROF — 直观对比
营收规模更大
PROF
是对方的1.7倍
$3.5M
净利率更高
PROF
高出4.5%
-141.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5M | $6.0M |
| 净利润 | $-5.0M | $-8.2M |
| 毛利率 | 12.1% | 66.8% |
| 营业利润率 | -141.7% | -123.3% |
| 净利率 | -141.2% | -136.8% |
| 营收同比 | -13.1% | — |
| 净利润同比 | -546.8% | — |
| 每股收益（稀释后） | $-11.09 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CYCUPROF
| Q4 25 | $3.5M | $6.0M | ||
| Q3 25 | $3.8M | $5.1M | ||
| Q2 25 | $3.9M | $2.0M | ||
| Q1 25 | $3.9M | $2.3M | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $4.2M | — |
净利润CYCUPROF
| Q4 25 | $-5.0M | $-8.2M | ||
| Q3 25 | $-3.1M | $-8.0M | ||
| Q2 25 | $-5.3M | $-15.7M | ||
| Q1 25 | $-10.2M | $-10.7M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $116.1K | — | ||
| Q2 24 | $306.1K | — | ||
| Q1 24 | $-312.5K | — |
毛利率CYCUPROF
| Q4 25 | 12.1% | 66.8% | ||
| Q3 25 | 7.1% | 77.7% | ||
| Q2 25 | 6.1% | 81.7% | ||
| Q1 25 | 17.5% | 79.2% | ||
| Q4 24 | 37.9% | — | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | 20.5% | — | ||
| Q1 24 | 8.2% | — |
营业利润率CYCUPROF
| Q4 25 | -141.7% | -123.3% | ||
| Q3 25 | -118.2% | -176.2% | ||
| Q2 25 | -96.9% | -696.9% | ||
| Q1 25 | -260.9% | -477.0% | ||
| Q4 24 | 31.9% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | -0.8% | — |
净利率CYCUPROF
| Q4 25 | -141.2% | -136.8% | ||
| Q3 25 | -81.5% | -157.7% | ||
| Q2 25 | -136.1% | -792.3% | ||
| Q1 25 | -264.8% | -458.1% | ||
| Q4 24 | 27.5% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 6.1% | — | ||
| Q1 24 | -7.4% | — |
每股收益（稀释后）CYCUPROF
| Q4 25 | $-11.09 | $0.27 | ||
| Q3 25 | $-1.59 | $0.26 | ||
| Q2 25 | $-0.15 | $0.52 | ||
| Q1 25 | $-0.56 | $0.36 | ||
| Q4 24 | $1.56 | — | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $20.1M | $66.4M |
| 总资产 | $33.5M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资CYCUPROF
| Q4 25 | $5.3M | $59.7M | ||
| Q3 25 | $3.7M | $24.8M | ||
| Q2 25 | $1.0M | $35.2M | ||
| Q1 25 | — | $46.4M | ||
| Q4 24 | $38.7K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务CYCUPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CYCUPROF
| Q4 25 | $20.1M | $66.4M | ||
| Q3 25 | $19.1M | $32.1M | ||
| Q2 25 | $14.0M | $39.3M | ||
| Q1 25 | $12.9M | $50.8M | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $-3.4M | — | ||
| Q1 24 | $-2.8M | — |
总资产CYCUPROF
| Q4 25 | $33.5M | $77.5M | ||
| Q3 25 | $32.3M | $42.3M | ||
| Q2 25 | $30.7M | $49.7M | ||
| Q1 25 | $31.5M | $60.9M | ||
| Q4 24 | $25.6M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.1M | — |
负债/权益比CYCUPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.3M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | $-3.5M | — |
| 自由现金流率自由现金流/营收 | -98.8% | — |
| 资本支出强度资本支出/营收 | 5.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.5M | — |
8季度趋势，按日历期对齐
经营现金流CYCUPROF
| Q4 25 | $-3.3M | $-6.6M | ||
| Q3 25 | $-2.5M | $-9.6M | ||
| Q2 25 | $-3.6M | $-13.7M | ||
| Q1 25 | $-2.7M | $-8.3M | ||
| Q4 24 | $-205.7K | — | ||
| Q3 24 | $-315.2K | — | ||
| Q2 24 | $-578.0K | — | ||
| Q1 24 | $-272.4K | — |
自由现金流CYCUPROF
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $-310.7K | — | ||
| Q3 24 | $-420.2K | — | ||
| Q2 24 | $-711.0K | — | ||
| Q1 24 | $-377.4K | — |
自由现金流率CYCUPROF
| Q4 25 | -98.8% | — | ||
| Q3 25 | -66.9% | — | ||
| Q2 25 | -94.2% | — | ||
| Q1 25 | -72.7% | — | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | -9.4% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | -8.9% | — |
资本支出强度CYCUPROF
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.5% | — |
现金转化率CYCUPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.18× | — | ||
| Q3 24 | -2.71× | — | ||
| Q2 24 | -1.89× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
